Clinical trials for Angioimmunoblastic T-cell lymphoma
7 recruiting or active trials synced from ClinicalTrials.gov.
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data- RECRUITINGPhase 2NCT07168317Tislelizumab , Cyclophosphamide, Mitoxantrone Liposomes, Chidamide, and Prednisone in the Treatment of New Diagnosed AITLThe Affiliated Hospital of Xuzhou Medical University · PI: Wei Sang Doctor
- RECRUITINGPhase 3NCT06522737A Study of Duvelisib Versus Gemcitabine or Bendamustine in Participants With Relapsed/Refractory Nodal T Cell Lymphoma With T Follicular Helper (TFH) PhenotypeSecuraBio
- RECRUITINGPhase 2NCT07058103Tislelizumab , Cyclophosphamide, Mitoxantrone Liposomes, Chidamide, and Prednisone in the Treatment of R/R AITLThe Affiliated Hospital of Xuzhou Medical University
- RECRUITINGPhase 2NCT06756308A Study of Enasidenib in People With T-Cell LymphomaMemorial Sloan Kettering Cancer Center · PI: Zachary Epstein-Peterson, MD
- RECRUITINGPhase 1NCT06393738A Study of ARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma.Arvinas Inc.
- ACTIVE NOT RECRUITINGPhase 4NCT07046182Clinical Study of CEP+Dasatinib + Azacytidine in First-line Treatment of. Angioimmunoblastoma ForesightZhengzhou University
- ACTIVE NOT RECRUITINGPhase 3NCT03703375Efficacy and Safety of Oral Azacitidine (CC-486) Compared to Investigator's Choice Therapy in Patients With Relapsed or Refractory Angioimmunoblastic T Cell LymphomaCelgene · PI: Bristol-Myers Squibb